Answers are grounded in this paper and cite their sources.
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma and affected patients’ outcomes vary from the extremes of cure in the majority of patients to the dismal prognosis of primary refractory and, to a lesser extent, relapsed disease that occur in 30–40% of cases. The
No takes yet. Share an insight, caveat, or question.
Kridel et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: